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ABSTRACT 
Clostridium difficile infection (CDI) was generally considered as a hospital-associated 
disease; however, recent studies indicated that foods might also play a role in its epidemical 
chain. From August-2013 to February-2014, oyster samples and harvesting water samples 
were collected monthly from 6 commercial oyster harvesting areas along Louisiana Gulf 
Coast and analyzed for total aerobic bacteria, fecal coliforms, coliphage and pathogenic    
C. difficile. In this study, C. difficile were isolated from 9 (47.37%) of 19 oyster samples and 
3 (37.5%) of 8 harvesting water samples and all isolations were carrying the toxin 
B-encoding gene (tcdB). Toxin B positive C. difficle was detected in all influent and effluent 
samples collected from a waste water treatment plant (WWTP) located in New Orleans, LA. 
However, the PCR-ribotyping showed that different strains of C. difficile were found in 
sewage effluent and oysters/harvesting water, suggesting the discharge of treated sewage 
might not contribute to the transmission of C. difficile into the harvesting areas. No statistical 
significance was found between the density of fecal coliform/E. coli in oysters and the 
occurrence of C. difficile, according to a binary logistic regression model (odds ratio = 1.025 
and 0.997). The concentration of Male-specific (F+) Coiphage and Somatic Coliphage in 
oysters was also found not to be directly related to the occurrence of C. difficile in oysters due 
to the low detection rate.  
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CHAPTER 1 
INTRODUCTION 
Clostridium difficile was originally regarded as part of the natural micro-flora of the 
intestinal tract until research on germ free rats showed decisive evidence that the 
microorganism was pathogenic to mammals in the absence of competing micro biota(Lessa 
and others 2012). C. difficle was later demonstrated to cause diarrhea, colitis, and 
occasionally could cause deaths, among human (Barbut and Petit 2001). The demonstration 
that C. difficile is pathogenic catalyzed a series of studies in the 1970s and several significant 
characteristics of C. difficile were revealed. First Green (1974) found a C. difficile-associated 
cytotoxin in the stools of guinea pigs that developed gastroenteritis after receiving ampicillin 
(Green 1974). In the same year, Tedesco and others. found that the use of clindamycin was 
also associated with the development of pseudomembranous colitis (PMC) caused by      
C. difficile (Tedesco and others 1982). Later Barlett and others (1977) isolated C. difficile 
species from hamsters with clindamycin-induced colitis and finally confirmed the role of   
C. difficle in antibiotic associated gut diseases.  
Epidemiology studies soon followed and showed astounding facts on the prevalence of this 
pathogen. Based on hospital patients, 10~25% of all cases of antibiotic-associated diarrhea in 
industrialized countries are caused by C. difficile, a microorganism once regarded as a 
common resident in the human intestinal tract (Burkhardt and Calci 2000). In healthy infants, 
the carriage rate of C. difficile ranged from 2~60% according to several reports and up to 17.5% 
of healthy adults were reported as asymptomatic carriers of C. difficile. Additionally,       
C. difficile was proved to be highly contagious between carrier and non-carrier patients in 
hospitals and health-care facilities. According to Riggs and others., the transmission rate 
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could reach up to 21.4% (Riggs and others 2007). The data from European studies reported a 
mean incidence of healthcare-associated C. difficile infection (CDI) of 4.1 per 10,000 hospital 
patients. However, the numbers vary greatly in response to the hygiene and instruments in 
surveyed hospitals and those located in less-developed areas may have an infection rate as 
high as 36.8 per 100,00 patients. CDI used to be a healthcare-acquired infection while in 
advanced areas, such as in Europe and North America, CDI associated with hospitals and 
nursing facilities has dropped to 25% of the total CDI cases due to proper surveillance.  
Community-acquired C. difficile infection (CA-CDI) has been becoming a more common 
CDI entity than previously perceived. In the USA, incidence rates of CA-CDI ranged from 
6.9 to 46 cases per 100,000 person per year. Worldwide, approximately 11–28% of patients 
with CDI acquire the infection in the community, which does not vary much between 
countries and areas (Barbut and Petit 2001). Besides a wider spread region, C. difficile also 
gained higher virulence and has been causing more severe diseases. The increasing severity in 
the disease was partly related to the emergence of hypervirulent strains, for instance, 
NAP1/BI/027, which stands for North American pulse-filed type 1 by PFGE, restriction 
endonuclease analysis group BI and PCR-ribotype 027. Research in recent decades has 
proven a significant correlation between NAP1 and increased morbidity and mortality of CDI, 
especially in the case of neopathies, such as toxic megacolon, septic shock, perforation, a 
higher fatality rate, and a poor clinical response to antibiotics such as metronidazole. The 
infection of NAP1 was also demonstrated to cause a much higher relapse rate (69%) than 
other C. difficile strains (15%~35%) (Marsh and others 2012). The increased virulence of this 
strain results from different mechanisms that may include the increased sporulation rate, the 
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production of a new binary toxins and the increased production of toxins resulting from 
impaired toxin-producing regulator gene clusters. NAP1 has different distributions among 
countries and was especially active in North America. In the most recent outbreak in May, 
2011 in Ontario, Canada, 26 health care facilities were involved and the report afterwards 
pointed out that it was closely related to NAP1 C. difficile.    
Other emerging hypervirulent genotypes, such as ribotype 078, were also isolated in 
several C. difficile outbreaks. Now C. difficile has overcome norovirus to become the most 
significant cause of deaths associating with gastroenteritis. In 2011, there were 17,414 
reported C. difficile related deaths in the UK, accounting for 1.1% of all deaths in England 
and Wales between 2006 and 2010. In the United States, C. difficile causes 14,000 deaths 
each year and have caused heavy financial burdens to the government. Generally, each case 
of C. difficile infection will result in a health-care cost of $3,600 and these costs have been 
exceeding more than 3.2 billion annually from the year of 2002 through 2010 (Warny, Pepin 
and others 2005; Dubberke, Haslam and others 2011). The occurance of new hypervirulent 
strains, such as ribotype 027 and 078, not only has brought about more CDI cases each year, 
but added extra debt to the government due to the high relapse rate. 
Many diagnosis methods had been developed since C. difficile became a growing threat for 
public health. Generally these methods can be divided into two types in terms of detection 
target: toxin or gene. The most representative toxin-detecting method is the cytotoxin assay 
(CYT), which was developed by Chang and others (2000). This method specifically detects       
C. difficile toxins with antitoxin-protected and nonprotected cell monolayers. CYT has been 
regarded as the golden standard method for comparison in toxin kit evaluations and giving 
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highly sensitive and specific detection of C. difficile. Other toxin-targeting methods may 
include cytotoxogenic culture (CYTGC), which is a similar method to CYT with a modified 
sample preparation procedure. Enzyme immunoassays (EIAs) and Lateral-flow assays use 
different enzymes to rapidly detect C. difficile-specific glutamate dehydrogenase (GDH) 
antigen and toxin A/B. The DNA-targeting methods are mainly based on the polymerase 
chain reaction (PCR). Using specific primers, the gene segments in pathogenicity locus, a 
19.6kb chromosomal segment containing tcdA-E gene, can be amplified and further specified 
by size through electrophoresis. The most widely used target gene is tcdB gene that encodes 
C. difficile toxin B, a highly prevalent toxin produced by virulent C. difficile strains. In 
comparison to traditional toxin typing methods, gene-targeting based methods showed higher 
specificity and sensitivity. An evaluation of the PCR assay detecting tcdC gene of C. difficile 
reported a sensitivity and specificity values of 86% and 97%, respectfully (Eastwood and 
others 2009).  
The isolation of high virulence, epidemic ribotype 078 C. difficile from calves and pigs 
indicated the possibility of interspecies transmission of C. difficile from animals to humans 
(Jhung and others 2008). In 2007, a study conducted in the USA found forty-two percent of 
retail meat products had toxigenic C. difficile strains that were ribotype 078/toxinotype V 
(73%) and 027 (27%). There were also surveys of C. difficile in waters and shellfish products 
from Europe claiming a higher prevalence of virulent C. difficile than formerly perceived 
(Pasquale and others 2012; Yam and others 2000). Therefore, foods could be a source of    
C. difficile and may have been involved in the increased relapse rate of CDI. N.AL Saif and 
J.S. Brazier (1996) reported the prevalence of C. difficile in water in South Wales and their 
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observation was confirmed by other researchers in different locations (Zidaric, Beigot and 
others 2010; Pasquale, Romano and others 2012). C. difficile spores were also isolated from 
soil, unwashed raw vegetables, shellfish, animals and livestock (Metcalf, Avery and others 
2011; Pasquale, Romano and others 2012).  
The occurrence of C. difficile in foods and water might have contributed to the increased 
numbers of carriers who possess a higher chance of getting CDAD when treated with 
antibiotics. On the other hand, although C. difficile is not likely to induce infections among 
healthy people, elder people and those who newly received antimicrobial treatment are still at 
high risk of receiving CDAD or relapse when exposed to contaminated foods and water.  
Oysters, belonging to the bivalve molluscs family, are one of the most important seafood 
products in the United States. Louisiana produces around 520 million oysters each year, 
which accounts for around 60% of oysters in the Gulf Coast region and about one-quarter of 
the nation's supply. Therefore, the safety of these oysters is crucial to both public health and 
the Louisiana oyster harvesting industry. As filter feeders, oysters are able to concentrate 
micro particles to folds higher than their exposure in the surrounding waters thus are ideal 
reservoir of many bacterial and viral pathogens. 
 C. difficile can spread through the fecal-oral route and its spores are highly resistant to 
normal chlorination-based or UV treatment. In Louisiana, most sewage will be treated first in 
the wastewater treatment plant (WWTP) and then discharged to wetlands for further 
purification. The Thibodaux site, one of several wetlands located in the Mississippi river delta, 
has been receiving secondarily treated municipal wastewater at the average rate of 15,140 m3 
per day since 1992. Therefore, with such a large amount of sewage eluted each day, the 
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spread of C. difficile may become a health threaten since the spores can survive and 
accumulate in environment for a long time period (Barbut and Petit 2001). Romano et.al has 
isolated 13 profiled and 8 unknown strains of C. difficile from both influent and effluent of 
nine waste water treatment plants (WTTP) in Switzerland, indicating that treated human 
sewage as another source of environmental C. difficile contamination (Vincenza Romano 
2012). In addition, there are studies showing that the efficacy of removing microbes in WTTP 
drops drastically during storm and rainny weather, as the water drainage becomes too much 
to be treated properly. 
 For the entire United States, excluding Hawaii and Alaska, the average amount of 
moisture falling as rain and snow is 30.21 inches (80cm). In terms of Louisiana, the annual 
rainfall can reach 64.2 inches (163 cm) and stormy weather can be seen occasionally in the 
summer. Therefore, there can be a higher chance for C. difficile to overpass WTTP and enter 
the outside water body. On the other hand, Louisiana annually sells more than 330,000 
hunting licenses and 900,000 fishing licenses that allows people to hunt, fish, boat, swim, 
camp, hike and paint in wetlands area. Considering the high carriage rate of C. difficile 
among human, the disposal of waste and sewage by the tourists may contribute to the spread 
of C. difficile in the water system. In order to properly control the hazard, monitoring of the  
C. difficile level in the environment, particularly in food-producing areas, is needed. This 
study will focus on detecting C. difficile in the oysters, oyster-bed water and sewage water in 
and near the Louisiana oyster harvest areas.    
The oysters and harvesting water were periodically collected and processed according to 
the standard method described by APHA’s Recommended Procedures for the Examination of 
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Sea Water and Shellfish, 4th ed., 1970. A two-step bacteria culture method was used to 
propagate and preliminarily detect C. difficile in collected samples. Further confirmation and 
virulence determination was realized by a Real-time PCR method described by van den Berg 
and coworkers, which aims to amplify C. difficile toxin B encoding gene, tcdB (van den Berg 
and others 2005). Total aerobic bacteria was enumerated as a background and used to 
determine the abundance of microorganisms in samples upon each sampling activity. 
Traditional fecal indicators: coliforms and E. coli, which are standard markers of fecal 
contamination, was partly evaluated to investigate their potential as an indicator of C. difficile 
contamination. The count of indicator bacteria will be performed with a five-tube serial 
dilution most probable number (MPN) method, according to the Bacteriological Analytical 
Manual, FDA. 
Two novel fecal indicators, Male-specific (F+) RNA coliphage and somatic coliphage, 
which have been suggested as an advanced alternative of fecal coliform for the evaluation of 
fecal contamination, was evaluated. These two types of coliphage have been successfully 
used in the indication of viral contamination since they are able to better simulate reaction of 
viruses to waste water treatment and harsh environmental conditions. C. difficile will be 
largely eliminated in WWTP as other bacterial pathogens, but the spores may persist as 
viruses do: although chlorination and UV could eliminate most vegetative cells, they are less 
effective against spores and viruses. Therefore, the coliphages, which are highly resistant to 
waste water treatment and can live longer in environment conditions, might be a more 
suitable indicators of C. difficile, in comparison to fecal coliforms. The count of fecal 
indicators was performed with a double-layer plating method. To determine if the discharge 
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of treated sewage is associated with the presence of C. difficile in the harvesting area, the 
harvested C. difficile both from sewage treatment plant and oysters and harvesting water was 
tested with a modified PCR-ribotyping method. The aim of this PCR-ribotyping is to 
discriminate if the same strains of C. difficile appear in the sewage and harvesting area and 
give a preliminary conclusion about the effect of sewage discharge on C. difficile spread in 
oyster harvesting areas. Also by comparing the C. difficile type between oysters and seawater, 
a clue might be obtained if the oyster bio-accumulate C. difficile from water body.  
The sampling sites of oyster and water were six neighboring areas selected from 28 
commercial harvesting areas defined by Department of Health and Hospitals, Louisiana. 
These areas are located near the exit of Mississippi River to the sea thus are good references 
for examining possible sewage contamination from upstream discharges. A representative 
municipal WWTP in New Orleans was selected for this study. This facility is permitted to 
treat 122 million gallons per day (MGD) as an Annual Average Daily Flow and saw an 
average flow of 98 MGD for 2013. Both influent and effluent sewage was sampled and tested 
for C. difficile to determine the efficacy of C. difficile removal from waste water treatment.  
Briefly, the objective of this study was to determine the prevalence of C. difficile in 
Louisiana oysters, harvesting water and sewage. To the best of our knowledge, this is the first 
survey about C. difficile in Louisiana oysters and waters and it may give usable data for 
further work to control this pathogen.  
 
 
 
 9 
 
CHAPTER 2 
LITERATURE REVIEW 
2.1 Clostridium difficile 
Clostridium difficile is a gram-positive, strictly anaerobic and spore-forming bacillus. It 
was first discovered in the intestinal floral of a fetus in the 1930s and was designated as a 
major cause of antibiotic-related diarrhea in the 1970s (Dubberke and others 2010). Toxins 
are the main virulence factors of C. difficiles: mainly toxin A and B from the large clostridial 
toxin family and sometimes an additional binary toxin. In the form of spores, C. difficile 
manages to survive high dose of antimicrobial drugs (which are usually employed to cure 
other infections), and out compete regular bowel flora and cause C. difficile infections (CDI). 
There are typically three manifestations of CDI development: asymptomatic carrier state, 
colitis with or without pseudomembranes and fulminant colitis. Asymptomatic state is quite 
prevalent among the population while no clinical treatment by far has been proved to be 
effective in elimination of C. difficile spores carried by healthy people; pseudomembranes 
colitis occurs in more than 50% of C. difficile infection cases with symptoms of fever, chills, 
and tenesmus in addition to common CDI symptoms like pain (usually crampy), malaise, 
nausea and vomiting; Although only representing less than 10% of symptomatically 
infections, fulminant colitis is the most dangerous state of CDI that may require the infected 
patients to take colectomy (Dubberke, Haslam and others 2011).  
Vegetative cells of C. difficile are extremely sensitive to oxygen thus the generally 
accepted pathogenic form of C. difficile are spores. Upon releasing, the spores remains 
dormant and have a strong resistance to undesirable environment conditions with a prolonged 
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survival period. Once an ideal growth environment is available, for instance, when they are 
ingested by humans or animals, the spores germinate, become vegetative cells and start 
producing toxins. C. difficile spores can survive routine environmental cleaning with 
detergents (Gerding, Muto and others 2008) and are capable of persisting on hard surfaces for 
as long as 5 months. Since C. difficile spores are shed from feces, any device that becomes 
contaminated with feces can be a reservoir.  
The invasion of C. difficile can be briefly described by an established model. When a 
healthy adult intakes C. difficile spores, the spores will survive its path through stomach into 
the duodenum and jejunum. The high concentration of bile salts and nutrients in the jejunum 
will aid in the germination of spores. The germinated spores will further travel to cecum, 
which is a strict anaerobic environment, through the ileum. Here most normal gut flora 
metabolize cholate derivatives, which is a promoter of C. difficile growth, and produce 
deoxycholate. Deoxycholate inhibits the growth of vegetative C. difficile cells thus no 
colonies of C. difficile can be formed. The spores may still germinate but without colony 
forming no toxin can be produced and released.  
However, once the normal flora are killed with antibiotics, the reduction of species that are 
able to dehydroxylate chalote will lead to the overgrowth of C. difficile. Deoxycholation of 
primary bile salts is the most important and effective defensive mechanism against C. difficile 
and even after standard therapy, such as vancomycin or metronidazole, the patients and 
practitioners still need to be very careful about relapse before normal gut flora is fully 
recovered (Sorg and Sonenshein 2008). 
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The strains of concern recently are ribotype 027/NAP1/toxinotype III and ribotype 
078/toxinotype V due to their prevalence in multiple outbreaks. Ribotype027 is characterized 
with increased virulence and relapse rate, which is thought to be associated with a one base 
pair deletion at position 117 of the tcdC gene, which impaired the negative regulation 
mechanism of toxin production. The malfunction of negative regulator further leads to an 
increased or prolonged production of toxins A and B. Production of an extra binary toxin was 
also determined in this ribotype. Ribotype 078, on the other hand, present a closer relation to 
our daily foods and multiple studies have pointed out the prevalence of C. difficile ribotype 
078 in livestock and retail meat products (Jhung and others 2008; Lessa and others 2012). 
C. difficile nowadays is still a big threat to public health and has imposed financial pressure 
on government. The presence of new, hypervirulent epidemic strains has been making 
prevention, diagnosis and therapy more difficult and more costly. The evidence that C. 
difficile can transmit through foods and water are warning us of its potential hazard if no 
action is taken to monitor and control its spread.  
 2.2 Toxins 
There are two major toxins produced by C. difficile, enterotoxin A consists of 2710 
residues (308.0kDa) and cytotoxin B consists of 2366 residues (269.6kDa) (Sullivan, Pellett 
and others 1982; Reinert, Jank and others 2005; Jank, Giesemann and others 2007). The 
structures of the two toxins are showed in Figure 2. Both toxins are glycosyltransferases that 
could modify small GTPtase in host cells (Geric, Carman and others 2006). Toxin A had been 
proven to cause severe epithelial damage with hemorrhage and diarrhea in rabbit ileal loops 
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tests (Lyerly, Lockwood and others 1982; Mitchell, Ketley and others 1986). Hecht and 
coworkers further concluded that toxin A can directly diminish the barrier effect of human 
intestinal epithelial cells by exerting an alteration to the permeability of tight junction and 
affecting the function of F actin (Hecht, Pothoulakis and others 1988). Their conclusions 
were confirmed later in investigations concerning the interferences toxin A and B exert on 
Rho proteins, a family of proteins closely associated with actin cytoskeleton regulation, 
epithelial barrier function and immune cell migration of human intestinal epithelial cells (Just, 
Fritz and others 1994; Jank, Giesemann and others 2007).  
Toxin B, on the other hand, does not cause mucosal damage in in-vivo animal models 
though it does elicit alterations in the cytoskeleton of cultured mammalian cells and cause 
inflammation (Riegler, Sedivy and others1995). Lacking of direct enterotoxic effects has led 
to an underestimation of toxin B until investigators recently found its significant role in the 
virulence of C. difficile (Riegler, Sedivy and others 1995; Lyras, O'Connor and others 2009). 
The discovery of several strains of toxin A negative but toxin B positive strains of C. difficile 
also supports the theory that toxin B, instead of toxin A, is the key virulence factor (Depitre, 
Delmee and others 1993; Alfa, Kabani and others 2000).  
In addition to large clostridial toxin A and B, a novel binary toxin consists of two unlinked 
molecules: CDTa (enzymatic component) and CTDb (receptor-binding component) were 
isolated from new strains of C. difficile (Warny, Pepin and others 2005; Geric, Carman and 
others 2006). Binary toxin is a type of ribosyltransferase that disrupts actin cytoskeleton of 
host cells and the presence of which is highly suspected relating to the increasing severity of 
CDI symptoms (Barbut, Decré and others 2005; Geric, Carman and others 2006). Binary 
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toxin CDT genes are found in less than 10% of clinical C. difficile isolates and its role in the 
development of disease was hard to determine since most CDT gene carrying C. difficile 
strains also carry the clostridial toxin encoding genes (i.e. tcdA and tcdB). In a recent study, 
Geric and coworkers reported that the CDT gene plays an important role in the accelerated 
development of CDI and can cause gastroenteritis independently (Geric and others 2006). 
Therefore, the emergence of CDT gene carrying C. difficile strains has raised a new task for 
the practitioners. 
All three toxins invade cells through endocytosis and the procedure can be described by a 
model. First the toxins bind to the receptors on the surface of a target cell and get 
endocytosed; then the low pH of endosome acidifies the toxins and induces a conformational 
change – the hydrophobic region of the toxins is exposed and the whole toxin-containing 
endosome is inserted through the membrane; Finally the toxins form pores on the endosome 
and are released to cytosol (Thelestam, Florin and others 1997; Jank, Giesemann and others 
2007). The structure of toxin A and B are showed in Figure 2.1. 
 
Figure 2.1. Structure of toxin A and toxin B (Jank, Giesemann and others 2007) 
 
The relapse of C. difficile partly attributes to the promoting effect of the toxins in C. 
difficile colonization and neutrophil chemotaxis activation. The use of wide spectrum 
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antibiotics as therapy such as vancomycin and metronidazole will also allow the invasion of 
other intestinal pathogens, for instance, Staphylococcus aureus and Enterococcus spp. to 
colonization in digestive tracts. Therefore, antitoxin might be a good aid through the therapy 
of C. difficile. Kink et al. have reported their success in the development of avian antibodies 
that neutralize both toxin A and B. They found that antibodies held the same ability in 
inhibiting C. difficile and, by neutralization of these toxins with antibodies, the pathogenic 
mechanism of the organism is blocked, its ability to thrive in the gut can be diminished. 
However, the cost of antibodies is still a block of wide application of antibiotics worldwide to 
deal with CDI.   
The production of multiple toxins by C. difficile can happen rapidly in 24 hours following 
infection. The speed of toxin accumulation varies from different C. difficile strains, with a 
generally higher toxin-producing activity observed in NAP1/BI/027 than other strains. 
According to Warny et al., under ideal conditions, the maximum toxin production speed was 
reached at 24h following incubation, when the cell density achieved maximum and the 
growth entered stationary phase. With little difference in the maximum cell concentration 
(17%, showed in Figure 2.2), the peak median concentration of toxin A was 16 times higher 
in hypervirulent strain NAP1/BI/027 (toxintype III)  than in toxintype 0; toxin B 
concentrations were 23 times higher in the toxintype 0, as is showed in Figure 2.3 (Warny 
and others 2005). 
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Figure 2.2 Growth curves of toxinotype 0 and toxinotype III (Warny and others 2005). 
 
 
Figure 2.3: In-vitro production of toxins A and B by C difﬁcile isolates (Warny and others 
2005). 
2.3 Epidemiology  
C. difficile is currently the most impending nosocomial diarrhea causer that has led to 
many large outbreaks in health-care facilities. In more than 95% PMC cases and 15-25% 
antibiotic-associated diarrhea (AAD) cases, C. difficile toxin B was isolated from the stool of 
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patients (Barbut and Petit 2001). More than 90% of C. difficile infections happen during or 
after antibiotic treatment when the colonic flora of patients is disrupted, allowing C. difficile 
to colonize and release toxins. In a 10-year study performed by Olson et al., 93% of a total of 
908 cases were associated with health-care facilities, where antibiotic treatments are 
implicated (Olson, Shanholtzer and others 1994). Epidemiology studies also suggested a high 
carriage rate (5.9%-11%) of people admitted to hospital and a high acquisition rate (4%-32%, 
basically through the oral-fecal pathway) in hospitals, indicating hospitals as an important 
source of C. difficile contagion (Barbut and Petit 2001). Besides hospital settings, C. difficile 
also causes diarrhea in the community and an increase in the community-associated CDI was 
seen. According to a recent study conducted by Beaugerie et al., C. difficile infections are 
responsible for approximately 1.5% of post- antibiotic treatment diarrhea in the community 
(Beaujerie, Flahaut and others 2001). Almost all antibiotics could contribute to the 
development of C. difficile-associated diseases and orally-taken broad spectrum drugs (such 
as penicillin and clindamycin) are usually the direct causes of infections. The overall 
acquisition rate of CDAD by people older than age 65 was several fold higher in people age 
45-65 thus CDAD is particularly dangerous to people older than 65 years or with other 
potential illness due to the enfeebled immune system brought by diarrhea and tissue 
inflammation (McDonald and others 2006; Barbut and Petit 2001)  
The attributable mortality rate of CDI varies from the infected population and epidemic C. 
difficile strains. (Warny, Pepin and others 2005). A 6-month study among 1430 Canadian 
patients in the year of 2009 gave a high death rate of 5.7%, which was almost 4-fold higher 
than the death rate given by a similar surveillance performed in 1997 (Gravel, Miller and 
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others 2009). Specifically, severely infected people acquiring colectomy will face a much 
higher mortality of 35-50% (Morris, Zollinger and others 1990). The epidemiological studies 
of C. difficile over the past decade were not showing promising results as was previously 
expected. The worldwide spread of novel, hypervirulent C. difficile strains like ribotype 027 
and 078 were largely responsible for the unsatisfying results. These new strains have been 
proven to induce more massive, hospital-associated, severer and poorer treatment-response 
infections. Community-associated incidences also increased with more young individuals and 
other formerly-considered low CDI-risk population involved (Weese 2010). The detection of 
C. difficile, especially ribotype 078, in foods, the environment and recreational waters, also 
suggested that C. difficile might have found a new way, without our perception, to invade and 
cause diseases. 
Another challenge to clinicians and epidemiologists is the high reoccurrence rate of CDI. 
Approximately 15 to 35% of patients with a first episode of CDAD relapse within 2 months. 
The mechanism of the re-infection remains unclear but some prospective studies pointed out 
that almost half of the reoccurrences are re-infections of a different strain of C. difficile 
(Johnson, Adelmann and others 1989; Barbut and Petit 2001). Therefore, proper prevention 
could be the most effective way of reducing C. difficile infections and re-infections (Barbut 
and Petit 2001).  
The main risk factors of C. difficile include increasing age (excluding infancy, when C. 
difficile presents a high carriage rate but does not cause disease), severity of underlying 
diseases, non-surgical gastrointestinal procedures, anti-ulcer medications, duration of hospital 
stay, duration of antibiotic course and administration of multiple antibiotics (Bignardi 1998). 
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In a survey between the years of 2000 to 2009, the CDI case per 1000 discharges from the 
hospital of patients older than 65 years old is significantly higher than that of patients less 
than 44 years old (Lessa and others 2012). Figure 2.4 shows their investigation results among 
patients differing by age, ranging from 18 to 85+ years old. 
 
Figure 2.4 Discharge rate for Clostridium difficile infection from US short-stay hospitals by 
age (Lessa and others 2012) 
Other information received from the survey is that there was a marked increase in CDI 
incidence and mortality across the United States in the last decade. In comparison to the year 
of 2000, there was nearly a 20% increase in CDI discharge for people older than 85 and C. 
difficile has become the 18th leading cause of death among people older than 65 years old 
(Lessa and others 2012). The emergence of a new strain of C. difficile, classified as restriction 
endonuclease analysis type BI, North American pulsed-field gel electrophoresis type 1 
(NAP1), PCR ribotype 027 (BI/NAP1/07) contributed largely to the current epidemiological 
status of C. difficile. Ribotyp027 possesses polymorphisms in an important toxin production 
down regulatory gene, tcdC that increases toxin production. Polymorphisms in tcdB that 
could result in improved toxin binding were also reported (Lessa and others 2012). A new 
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toxin, binary toxin was detected with Ribotype 027 and cdtA/cdtB gene located outside the 
traditional pathogenicity locus was determined as the encoding gene. Moreover, recent 
whole-genome comparative analyses have demonstrated that a number of genetic 
rearrangements have happened to epidemic ribotype027. Stabler and coworkers reported that 
the genome of the epidemic ribotype 027 added 5 more genetic regions compared with its 
historic counterpart (Stabler, He and others 2009). These additional genes may have 
contributed to the phenotypic differences between these strains relating to motility, survival, 
antimicrobial resistance, and toxicity.  
2.4 Treatment 
  Successful treatment of C. difficile infections requires a series of optimal management 
methods towards the case: prompt recognition, timely therapeutic actions, keeping up with 
observations and implementation of infection control measures (Pépin, Valiquette and others 
2005; Gerding, Muto and others 2008). Occurrence of more virulent strains of C. difficile has 
shortened the ideal time interval for most effective treatments to be applied thus the 
significance of rapid recognition is greatly emphasized. All clinicians, particularly nursing 
staff who can usually realize CDI signs 1-2 days ahead of physicians, should be fully alerted 
to any possible development of CDIs. Timely recognition could be as crucial as to prevent the 
development of deadly fulminant colitis and fast clinical deterioration of patients (Gerding, 
Muto and others 2008).  
Once CDI is diagnosed, the choice of initial therapy will depend on the severity of the 
infection: metronidazole (Mtz) is optimal for most cases while vancomycin is recommended 
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for severely ill patients and those with complicated or fulminant infections or multiple 
recurrences of CDI (Olson, Shanholtzer and others 1994). Monitoring of therapeutical 
responses (WBC count, temperature, abdominal examination, number of bowel movements, 
etc.) will be done during the treatment and usually patients will show some improvements 
within 1-2 days after the initiation of therapy. If the patient does not improve or even gets 
worse, the therapy should be immediately shifted to orally giving vancomycin with further 
examination performed. Any signs of ileus, obstruction, perforation, toxic mega-colon, 
colonic-wall thickening, or ascites should be seriously evaluated. If the situation is impending, 
a consultation of colectomy might be made as the only life-saving option at this phase of 
infection (Pasic, Jost and others 1993).  
Re-infection or relapse of C. difficle may happen 7-14 days after therapy and in some 
patients they may occur continuously year by year. An explanation of the frequently 
reoccurrence of CDI in the same patients is the weakened immune response to toxin A and 
the disruption of colonization protection of the normal colonic flora (Aas, Gessert and othres 
2003). Besides vancomycin and metronidazole, there are several other options for CDI 
treatment: probiotics and anion-exchange resins, intravenous immunoglobulin, nitazoxanide 
and rifximin.  
However, the application of robiotics, anion-exchange resins and intravenous 
immunoglobulin are trapped by their high costs and limited efficacy; Nitazoxanide and 
rifximin, which have been successfully used in CDI treatment, lack the approval of FDA 
(Gerding, Muto and others 2008). Although many guidelines of CDI treatment are available 
currently, the prevention of multiple recurrences of CDI is still challenging. More tests and 
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data are needed to verify these novel therapies and the costs of the drugs need to be further 
lowered for a wider application against the rising complexity of the disease.     
2.5 Detection of C. difficile  
The diagnosis of C. difficile generally relies on detecting the organism, its toxins, other 
cellular antigens, and toxin-specific genes. The cytotoxicity assay (tissue culture assay) for 
toxin B has been considered the "gold standard," for its high specificity and sensitivity. 
Generally it gives a 100~1000 fold higher sensitivity then the rapid enzyme linked 
immunosorbent assay (ELISA) methods and a 99%~100% specificity. This method is based 
on a characteristic cytopathic effect that can be observed and could be neutralized with 
anti-Clostridium sordellii antiserum. However, in exchange to the high performance, the 
tissue culture takes at least 48 h to produce the result and requires laborious work.  
The stool culture is considered to be the most sensitive detection method for C. difficile 
while it requires longer incubation time (72~96h) to yield reliable results and the lab work is 
more intense. An advantage of this method is that it provides a chance for further strain 
typing but non-virulent C. difficile may in turn interfere with the results. The most widely 
used method, both in laboratory and healthcare facilities, for diagnosis of C. difficile is 
ELISA. This group of method are based on the immunoassays for detecting toxins and 
antigens of C. difficile. ELISA has proven its usefulness in discriminating toxin A-negative, 
toxin B-positive (A-/B+) C. difficile variants and the ability to yield results in a few hours. 
This is very meaningful in the practical use in clinical diagnosis and many commercial 
available ELISA-based C. difficile detection kits were developed. However, the sensitivity 
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and specificity of these kits was not satisfying in comparison to traditional laboratory 
methods. According to several studies, the sensitivity of the rapid immunoassys to detect C. 
difficile fall below 60% in comparison to PCR-based detection of toxins A and B genes (van 
den Berg and others 2005). 
  PCR-based detection of C. difficile, on the other hand, gives better performance than 
ELISA and requires a reduced amount of time and work when compared to traditional culture 
assays. Moreover, PCR methods can be applied to the typing of different C. difficile strains 
and thus are able to satisfy multiple experimental intends simultaneously. There are by far 
more than 150 identified C. difficile PCR ribotypes that are marked with 3-digital numbers 
(003, 005, 027, 078 etc.) and the establishment of online C. difficile ribotype library has 
provided great convenience for the researchers to study the epidemiological properties of the 
microorganism.  
The toxicity of a C. difficile is basically decided by the structure of its pathogenicity locus, 
a 19.6kb chromosomal segment consists of tcdA-E genes. These genes encode toxin A (tcdA), 
toxin B (tcdB), a negative regulator (tcdC), a positive regulator (tcdD) and a pore-forming 
protein (tcdE). During the logarithmic phase, strong expression of tcdC gene but restrained 
transcription of others could be observed; inversed trend is seen in the stationary phase which 
confirms the tcdC as the negative regulator in production of C. difficile toxins. The 18-bp 
deletion in tcdC gene characterizes the new deadly strain of C. difficile NAP1/027, which has 
been causing severe outbreaks across Europe and North America.  
Besides the malfunction of tcdC gene, a ctd gene encoding binary toxin is also designated 
on the chromosome of NAP1/027. Cdt genes, including cdtA and cdtB, are located outside 
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the pathogenicity locus and have been found in several C. difficile strains. The presence of 
cdt gene and binary toxin is also speculated to relate severe CDIs. The variances in the 
structure of pathogenicity locus provide a base for C. difficile genotyping. Two most variable 
regions, A3 region in tcdA and B1 region in tcdB, have been used to detect variants or/and 
discriminate different C. difficile strains. Sole amplification of the A3 region possesses the 
ability to recognize 13 of 15 known toxin types and a full screen of both regions will further 
allow an allocation of tested strains into specific toxin types. However, although it is rarely 
seen for strains that do not generate toxin A and B but binary toxin (like C. difficile toxintype 
X), amplification of ctdB gene is recommended (Stubbs, Rupnik and others 2000). The 
detection of ctdB gene could also be a less time-consuming alternative of A3 segment screen 
in any binary toxin-producing strains, allowing the recognition 10 of 15 toxintypes (Stubbs, 
Rupnik and others 2000).    
 
 Figure 2.5 Major gene in PaLoc of C. difficile and CDT genes (Warny, Pepin  
and others 2005) 
2.6 PCR-based typing 
The most traditional typing method used was the slide agglutination with rabbit antisera, 
together with the protein profiles obtained by polyacrylamide gel electrophoresis (PAGE). By 
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far there were 14 serogroups determined by this method and are characterized by capitalized 
letters and numbers (A, B, C, D, F, G, I, K, S1, S2, S3, S4, and X) (Delmee and others 1986). 
Toxinotyping is a PCR-based assay used to type C. difficile isolates. It is a PCR-RFLP (i.e. 
Restriction fragment length polymorphism) analysis of a 19 kb region encompassing the C. 
difficile pathogenicity locus. PCR products are digested by restriction enzymes and the 
resulting restriction fragments are separated according to their lengths by gel electrophoresis. 
There are 16 C. difficile toxintypes (0-XV) reported and more toxintypes might be found. 
This method could be easily performed in routine laboratory practice and further applied to 
detect and characterize variant strains.  
Genotyping is based on the isolation and sequencing of specific gene segments in different 
C. difficile strains. One genotyping method is to target the tcdC gene, which functions in 
toxin regulation and secretion. Genotype tcdC-A is characterized by a nonsense mutation 
(C184T) and a 39-bp deletion from nucleotides 341 to 379. Genotype tcdC-A was identified 
in C. difficile isolates of toxinotypes V and VI. TcdC-B and tcdC-C were marked by 18-bp 
deletions at nucleotides 330 to 347. This deletion was found in C. difficile ribotype 027 and 
was proved to be responsible for the increased pathogenicity and infectivity of this strain. 
Besides toxintyping and genotyping, a PCR-ribotyping method developed by      
Kostman and coworkers (1992) was also shown to be reproducible, easy to perform and 
cost-effective. This typing method is based on the amplification of several alleles of the 
rRNA operon differing by the length of the intragenic spacer region located between the 16S 
and the 23S rRNA genes (Bidet, Barbut and others 1999). Thus, a PCR using one primer in 
the 16S rRNA gene and the other in the 23S rRNA gene will yield a series of amplified DNA 
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fragments with different length and molecular weight. The difference in sizes of DNA 
fragments from one sample to the other will make the banding pattern specific for certain 
strains of C. difficile.  
The establishment of C. difficile ribotyping library has been done by many laboratories 
using standard C. difficile strains isolated from feces of patients. For C. difficile, the bands 
usually located from 225 base pairs (bp) to 700 bp and nearly all the serogroups show 
different fingerprint-like patterns in banding. The novel PCR-ribotyping showed an 
extremely high reproducibility thus reliable results can be generated at any lab through a 
comparison between sample gel and established standards. Another advantage of this 
method lies in the situation that exact ribotype cannot be identified effectively (e.g. 
environmental sample with low concentration/less robust C. difficile). Observing the 
differences/similarities between banding patterns may also, at least, allow the researchers to 
determine if they discovered same/different strains of C. difficile under various sampling 
conditions.  
Figure 2.6 shows a gel image obtained from the PCR products of 10 different C. difficile 
strains by a modified PCR-ribotyping method developed by O’ Neil et al (1996). The 
banding patterns were well distinguishable due to the modification to the primer pairs, 
which generate smaller DNA fragments in response to a narrower interspace region between 
the binding sites of upstream and downstream primers. Generally, the smaller the DNA 
fragments generated by PCR-ribotyping, the more easily they are separated on an agarose 
gel matrix, which actually lacks resolution to differentiate between two high molecular mass 
DNAs with similar size.  
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Figure 2.6 PCR-ribotyping results for 10 C. difficile strains (Bidet, Barbut and others 1999) 
2.7 Fecal indicators 
 Fecal pollution has been a serious environmental problem that affects many coastal regions 
in the United States (Sinton and others 2002). Pathogens associated with feces will cause 
diseases if contaminated food products, such as shellfish and vegetables, are consumed. The 
sources of contamination may include inefficient sewage treatment plants, leaking septic 
systems, agricultural runoff, human activity or wildlife (Bernhard and Field 2000). 
Epidemiological study has indicated its presence as a fecal-associated pathogen from various 
sources, and most importantly, from human and animal feces (Barbut and Petit 2001). 
Although few comprehensive surveys were performed about the prevalence of epidemic C. 
difficle in human populations, the common asymptomatic carriage of C. difficile has been 
proved by a series of epidemiological research within healthcare facilities. Of the patients 
examined 5.9%~13% were carrying epidemic C. difficile strains upon admission to the 
hospital (Barbut and Petit 2001; Riggs, Sethi and others 2007) and a 4%~21% acquisition 
rate of C. difficile by non-carriers were also determined. Therefore, it is reasonable to 
presume that C. difficile has a higher presence rate among human now than it used to be (3% 
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in adults) and the daily discharge of human feces would contribute to the presence of C. 
difficile in sewage.  
The presence of C. difficile in surface water was also detected and this might lead to the 
transmission of C. difficile to farm produce since 74,900 million gallons of surface water is 
drawn per day in U.S for irrigation purpose. According to a research performed in South 
Wales, England, epidemic C. difficile strains were isolated from 14 (87.5%) of 16 samples 
from four rivers and 7 (44%) of 15 from seawater samples. In addition, 7 (46.7%) of 15 
samples of lake water were also positive (AI Saif and Brazier 1996). The most widely used 
detection method for fecal pathogens in water body is to quantify indicator bacteria by 
culturing techniques.  
Coliforms and fecal streptococci are two main groups of bacteria that are fecal indicators in 
water samples. They indicate the possible presence of pathogenic (disease-causing) bacteria, 
viruses, and protozoans that also live in human and animal digestive systems. Coliforms 
comprise a group of microorganisms that utilize lactose to produce acid and gas, or contain 
β-D-galactosidase, which is capable of using a chromogenic galactopyranoside substrate 
(Edberg and others 2000). Klebsiella, Serratia, Citrobactor, Enterobacter and Escherichia are 
the main members of this group while except for Escherichia spp., all other genera are widely 
found in the environment and are not necessarily related to fecal contamination. Many studies 
have reported E. coli as the only coliform that inhabits the gastrointestinal tract of human and 
animals. However, the routine test of E. coli used to be costly and laborious thus fecal 
coliforms, a group of facultative anaerobic, rod-shaped, gram-negative, non-sporulating 
bacterium, have long been used as the surrogate of E. coli in monitoring fecal contamination. 
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Although the majority of fecal coliforms were proven to be members of the genus Klebsiella 
(Edberg and others 2000), instead of E. coli, enumeration of fecal coliforms are still standard 
methods documented by the FDA (Chapter4, Bacteriological Analytical Manual, FDA).  
The emergence of a new technology, The Defined Substrate Technology (DST) in the 
1980s, permitted for the first time, the direct detection and identification of E. coli in 
environmental waters. The method is mainly based on detecting the metabolism of 
4-methy-umbellfieryl-,8-D-glucuronide (MUG), a compound that can only be utilized by a 
specific enzyme system carried by E. coli. This enzyme system, which was later proved to be, 
β-glucuronidase, is present in more than 95% of all isolates of profiled E. coli. The DST 
method allowed direct detection and enumeration of E. coli and coliforms with as low as only 
1CFU/100ml water sample. Traditional fecal indicators (e.g. fecal coliforms and E. coli) have 
been proven reliable in many occasions but they are non-spore formers thus may not be able 
to provide the most accurate information about C. difficile, especially through waste water 
treatment plants, where most vegetative cells are eliminated. In this case, two novel fecal 
indicators, F+-specific RNA coliphage and Somatic coliphage have been suggested as 
alternative indicators for enteric viruses and bacteria spores. 
 Coliphages are a group of nonpathogenic viruses that infect coliform bacteria, and act 
more similarly to bacterial spores with respect to environmental persistence, and resistance to 
treatment processes than are indicator bacteria (Sinton and others 2002). Varying from the 
level of sewage treatment, the consistent presence of coliphages in raw and treated sewage 
and have been reported in concentrations ranging from 103 to 107 PFU/liter. In addition, a 
variety of domestic and feral animals, especially seasonal birds, also shed coliphages in their 
 29 
 
feces. The male-specific (F+) coliphage received its name from their morphological 
characteristics that they infect only F+ male hosts through the F sex pilus. Besides F+ male 
specific coliphage, there are five more major groups of coliphage differing from 
morphological characters. Two F+ coliphage families are the Leviviridae (small, icosahedral, 
single-stranded RNA phages) and the Inoviridae (filamentous, single-stranded DNA phages) 
and both of which have been proven to be associated with viral contamination in raw and 
treated sewage, drinking water, and recreational waters. On the other hand, serotyping or 
DNA oligoprobing of the two F+ coliphage types have been used in identification and to 
distinguish between human and nonhuman fecal contamination sources. This is of great 
significance in the trace of source of fecal contamination and control the spread of enteric 
pathogens. In consideration to the fact that C. difficile spores are similar to enteric virus in 
environmental water and waste water treatment, coliphages might be a better alternative to 
traditional fecal coliforms as an indicator of C. difficile spread. To the best of my knowledge, 
this was the first study to look into the relationship between fecal indicators and C. difficile 
and the use of coliphages as indicators of pathogenic C. difficile groups. 
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CHAPTER 3 
METHODOLOGY 
3.1 Sampling  
Five commercial harvesting areas (Area 9-13) defined by the Louisiana Department of 
Health and Hospitals (DHH) were selected for this study. Oyster and seawater samples were 
randomly collected twice a month by DHH from these six areas. Sewage sample were 
collected on a monthly basis from a municipal waste water treatment plant (WWTP) in New 
Orleans. This facility is permitted to treat 122 million gallons per day (MGD) as an Annual 
Average Daily Flow and had an average flow of 98 MGD for 2013. The exact sampling sites 
are shown in Figure 3.1.  
Figure 3.1 Five commercial oyster harvesting sites along Louisiana Gulf 
Coast region (Google Earth v. 7.1.2.2041)  
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Figure 3.2 Municipal Waste Water treatment plant inNew Orleans, LA  
(Google Earth v. 7.1.2.2041). 
Both influent and effluent (i.e. untreated and treated waste water) were collected with 
sterile capped polypropylene bottles. Oysters and water samples were stored on ice under 4℃ 
in a walk-in cooler for no longer than 24 hours upon sample preparation. 
3.2 Sample preparation 
3.2.1 Oysters 
Prior to shucking, oysters were cleaned with a clean brush and flowing water to purge mud 
and parasites. Oysters were taken in pairs from sampling bags with approximately even sizes 
for uniformity. Oysters were shucked with sterile shucking knives and both meat and juice 
were gathered in a sterile filter bag. Homogenate was prepared in a sterile blender by 
blending the muscle and juice at full speed for 1 minute. The blender was cleaned with 10% 
bleach and sterilized under UV for 5 min between each sample. Prepared homogenate was 
placed on ice until used.  
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3.2.2 Harvesting water and sewage 
One liter of harvesting water sample was filtered through a Millipore filtration system 
(Millipore, Billerica, MA) with a vacuum pump. Bacteria was blocked and concentrated on a 
47mm (diameter), 0.45um-pore size cellulose filtration membrane (Millipore, Billerica, MA) 
and the filtrate was discarded. For sewage samples, 15ml of each influent and effluent water 
were filtered and concentrated with same instrument. The membranes were used immediately 
for further test. 
3.3 Detection of C. difficile in oyster samples 
Non-repeat regions on tcdA, tcdB and CDT genes (encoding binary toxin) are usually the 
choices of amplification targets in strain-specific PCR assays. Considering the emergence of 
toxin A-negative and toxin B-positive epidemic C. difficile strains, sole amplification of tcdB 
gene would be a feasible and economic choice. Therefore, a tcdB-targeting real-time PCR 
method described by Van den Berg and coworkers (van den Berg, Bruijnesteijn van 
Coppenraet and others 2005) was applied to determine the virulence of C. difficile in oyster 
and water samples.  
The copy number of C. difficile spores in environmental samples could be really low 
(Pasquale and others 2012) and might be hard to detect. Therefore, preliminary incubation 
was performed with BHI broth supplemented with 0.1% sodium taurocolic acid and       
C. difficile selective supplement (Sigma-Aldrich). Following processing, 15 g of oyster 
homogenate was added to 40 ml of Brain Heart Infusion broth (BHI) supplemented with 
cefoxitin (8 μg/ml) and D-cycloserine (250 μg/ml). Cefoxitin and D-cycloserine selectivity 
supported growth of C. difficile, while inhibiting growth of the majority of 
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Enterobacteriaceae, Streptococcus faecalis, Staphylococci spp., Gram negative, non-sporing 
anaerobic bacilli and Clostridia spp. Taurocolic acid sodium salt hydrate (1mg/ml) was added 
together with cefoxitin and D-cycloserine under sterile conditions into the autoclave BHI 
broth. The supplemented broth was stored in 50 ml polypropylene tubes under 4℃.  
Upon adding oyster samples, the BHI tubes were incubated anaerobically by a GasPak™ 
EZ Anaerobe Pouch System under 37℃ for 10 days. A loose cap was applied to the tubes to 
ensure an anaerobic environment in the space between the liquid surface and tube cap. 
Ethanol shock was performed to eliminate all vegetative cells except C. difficile spores for 
DNA extraction. Specifically, 2 ml of 96% ethanol was combined with 2 ml incubated broth 
and the mixture stayed at room temperature for 50 min. After ethanol shock, the sample was 
centrifuged at 6000 × g for 10 min and the supernatant was collected in sterile 2 ml 
centrifuge tubes. 
 For the confirmation of C. difficile, a commercial Clostridium difficile selective agar 
(CDSA) was used (BBL™ Clostridium difficile Selective Agar, BD) following the 
instructions of manufacturer. Briefly, the plates were first reduced anaerobically under room 
temperature for 24 hours before use. Then the supernatant collected from supplemented BHI 
broth was streaked on the plates under a certified bacteria hood and the inverted plates were 
incubated anaerobically (with the Gaspak system) at 37℃ for 24-48 hours. The formation of 
yellowish, round and elevated colonies indicated C. difficile and the colonies were further 
observed under long wavelength UV (380nm) to positively confirm. Specifically, C. difficile 
colonies on CDSA emit a glowing yellow fluorescence under long wavelength UV within 
approximately one hour in the presence of oxygen. DNA extraction was conducted right after 
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colonies of C. difficile were confirmed on CDSA plates and three colonies from each sample 
with approximately identical sizes were collected in a sterile 2 ml centrifuge tube.  
The DNA extraction was performed with a commercial DNA extraction kit according to 
the instructions of the manufacturer. Extracted DNA was stored under -80℃ if not used for 
PCR immediately. The primers used in the real-time PCR were specifically designed to 
amplify a 177 bp non-repeat region of tcdB gene (van den Berg and others 2005). The 
amplification reactions were performed in a 25 μl final volume, containing 12.5μl IQ 
supermix (Bio-Rad, Veenendaal, The Netherlands), 2.5 pmol of the forward primer 
(398CLDs), 5 pmol of the reverse primer (399CLDas), 4 mM MgCl2, 0.2 μM probe, and 2.5 
μl of sample DNA. After an enzyme activation step of 3 min at 95°C, the protocol consisted 
of 50 cycles of 30 s at 94°C for denaturation, 30 s at 57°C for annealing, and 30 s at 72°C for 
elongation. The PCR was performed using a Cepheid Smart Cycler PCR instrument (Cepheid, 
Sunnyvale, CA). The sensitivity of the method was 1 × 103CFU/ml (van den Berg and others 
2007). Table 3.1 shows the primers and probe used in this method. 
Table 3.1. Primers and probes used for real-time PCR detection of C. difficile 
Primers and 
probe 
Sequence (5’- 3’) Reference 
398CLDs GAAAGTCCAAGTTTACGCTCAAT Van den Berg and 
others 2005 
399CLDas GCTGCACCTAAACTTACACCA Van den Berg and 
others 2005 
551CLD-tq-F
AM  
FAM-ACAGATGCAGCCAAAGTTGTTGA
ATT-TAMRA 
Van den Berg and 
others 2005 
3.4 Detection of C. difficile in sea water and sewage samples 
Similar PCR procedure as was described above was used with some modifications in the 
enrichment step. Following filtration, the membrane filter was immersed in 40 ml BHI broth 
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supplemented with sodium taurocolic acid (0.04g/ml), cefoxitin (8μg/ml) and D-cycloserine 
(250 μg/ml).Incubation and DNA extraction was performed as was described above in section 
3.3. For sewage samples, 15 ml of effluent and 15 ml of pre-filtered (Whatman filter 40) 
influent water was filtered through 0.45-μm pore size filter nitrocellulose membrane filter 
(Millipore, Billerica, MA).  
3.5 Quantification of Fecal indicators in oyster 
Microbial indicators were analyzed in collected oyster meat samples according to APHA’s 
Recommended Procedures for the Examination of Sea Water and Shellfish, 4th ed, 1970. 
Total aerobic bacteria, Male-specific (F+) and Somatic coliphages, fecal coliforms, and     
E. coli were determined. A standard method agar (Acumedia, U.S.) was used for the aerobic 
plate count. A 10-fold dilution of oyster homogenate was prepared with phosphate-buffered 
saline buffer and the highest dilution was 1 to 1000. Briefly, 1ml of each diluted oyster 
homogenate was poured with 15ml standard method agar in duplicate. Two blank standard 
agar plates were incubated along each test as  Then the plates were incubated inverted at 35°
C for 48 hours. All colonies were enumerated, regardless of size, color, or morphology. Fecal 
coliforms and E. coli were enumerated using a 5-tube, 3-dilution most probable number 
(MPN) method with 1.5× Lauryl tryptose broth, Escherichia coli (EC) broth with or without 
4-methylumbelliferyl-β-D-glucuronide (MUG).  
Following processing, a 10-fold dilution (highest dilution 10-3) was prepared and 2ml of 
each dilution was added to each tube and incubated for 24 hours for gas formation. Gas 
formation in Durham tubes were regarded as positive for fecal coliform. Gas-negative LTB 
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tubes were incubated for another 24-hour period to confirm negatively. The 48-hour positive 
tubes were also recorded as positive and used for E. coli test. The calculation of CFU/g was 
determined by MPN calculator software. Positive LTB tubes (gas formation in Durham tubes) 
were then tested for E. coli and were transferred to EC broth tubes and incubated under 45℃ 
for 24 hours. Gas formation in EC broth within 24 hours indicated a high possibility of E .coli 
presence and samples were transferred to EC broth with MUG for final confirmation. EC 
MUG tubes were incubated for 24 hours under 45℃ for gas formation and were observed 
under 366nm UV light.  
Male specific (F+) and Somatic coliphage are viruses that infect E. coli thus the 
enumeration of the coliphage needed prepared E. coli cultures. E. coli F-amp, carrying a 
specific resistance to streptomycin and ampicillin, and E. coli CN13, which is engineered to 
be resistant to nalidixic acid, were used for the culture of Male specific and Somatic 
coliphage, respectively. Either streptomycin/ampicillin or nalidixic acid provided a selective 
pressure against microorganisms other than E. coli to ensure an ideal condition for the growth 
of coliphage. To achieve maximum number of E. coli cells, a log-phase incubation was 
applied. Overnight culture of each E. coli strain in antibiotics-supplemented (50μg/ml 
streptomycin/ampicillin and 334μg/ml nalidixic acid)Tryptic Soy broth (TSB) was further 
incubate for 4-6 hours in the same culture under 37℃ before plating. A double-layer method 
was used to quantify the coliphage in oyster samples. Approximately 15.0 g of oyster 
homogenate aliquots from each sample were placed into a sterile centrifuge tubes and in 1:3 
dilution with 30ml growth broth. Then the tube was centrifuged at 10,000 × g for 15 min at 
4°C. The supernatant was collected and weighed in a new, sterile 50ml centrifuge tube then 
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allowed to warm to room temperature for around 20 min. Then 2.5 ml of the supernatant will 
be combined with 2.5 ml of pre-autoclaved double-strength soft agar (tempered to 52℃) and 
200 μl of log-phase E. coli F-amp or E. coli CN-13.  
The mixture was mixed well by rolling the tube generally for around 10 times and 
overlayed onto a tryptone agar plate containing streptomycin/ampicillin (50μg/ml) for the 
Famp mixture or a tryptone agar plate containing nalidixic acid (334μg/ml) for the CN-13 
mixture. After the upper layer is hardened, the plates were inverted and incubated for 24 
hours at 37℃. A 10-9 and 10-8 dilutions of positive Somatic and F-amp coliphage sample 
collected from previous tests (sewage sample) were plated along with each sample as positive 
controls. Negative controls of 2.5ml of growth broth were used with the tested of oysters. The 
average PFU per 100 g of oyster meat and juice was calculated using the average PFU/plate, 
quantity of supernatant/plate, and the total weight of oyster meat and the formula:  
 
𝑃𝐹𝑈/100𝑔 𝑜𝑦𝑠𝑡𝑒𝑟 =
 𝐴𝑣𝑒𝑟𝑎𝑔𝑒 𝑃𝐹𝑈/𝑝𝑙𝑎𝑡𝑒
𝑠𝑢𝑝𝑒𝑟𝑛𝑎𝑡𝑎𝑛𝑡/𝑝𝑙𝑎𝑡𝑒 (𝑚𝑙)
×  
𝑇𝑜𝑡𝑎𝑙 𝑠𝑢𝑝𝑒𝑟𝑛𝑎𝑡𝑎𝑛𝑡 𝑟𝑒𝑐𝑜𝑣𝑒𝑟𝑒𝑑 (𝑔)
𝑇𝑜𝑡𝑎𝑙 ℎ𝑜𝑚𝑜𝑔𝑒𝑛𝑎𝑡𝑒 (𝑔)
 ×  100 
 
The relationship between the indicator and the occurrence of C. difficile in samples was 
determined by SPSS Statistics software, using a binary logistic regression process. The model 
was validated by a Chi-Square test hypnotizing significant deviances between the predicted 
and observed values. The insignificance of the test indicates the statistical model is effective.  
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3.6 PCR ribotyping 
The ribotyping of C. difficile depends on PCR amplification of several rRNA operon 
differing by length. Through an agarose gel electrophoresis, the PCR products formed unique 
banding patterns varying from one ribotype to the other, thus provide a typing ability between 
different species of C. difficile. Similar processing and DNA extraction was used as is 
decribed in the Real-time PCR detection of C. difficile. Differently, the instrument used in 
this part was a traditional PCR machine (Bio-Rad) thus no probe was included. Table 3.3 
shows the primers used in this method. 
Table3.3 Primers for PCR-ribotyping of C. difficle 
Primer Sequence Reference 
16S primer 5'-GTG CGG CTG GAT CAC CTC CT-3' 
Bidet and others, 
1999 
23S primer 5'-CCC TGC ACC CTT AAT AAC TTG ACC-3' 
Bidet and others, 
1999 
The 1.0% agarose gel was prepared with 1.0× Tris-acetate-EDTA (TAE) buffer and 
molecular agarose gel powder (Seakem). Briefly, 25 ml of 1.0× TAE buffer and 0.25 g of 
agarose gel powder will be mixed and heated to a slight boil in a 150 ml capped flask. Then 
the flask was incubated in a 50℃ water bath for 10 min to cool down to approximately 
60℃.Ethidium Bromide was added to the gel before pouring with a final concentration of 
50ug/L and mixed well. Pre-mixed 3 μl of loading dye and 15 μl of PCR amplifications was 
added to each sample loading slots after the gel was hardened. Then the DNA was fractioned 
by electrophoresis for 2 h at 35V in 1.0× TAE buffer for 2 hours with a distance of 10 cm 
between the two electrodes.  
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3.7 Data processing 
All analyses were performed in duplicate and reported with as mean per 100g or +/- (C. 
difficile). A binary logistic regression model was used to measure the contribution of each 
variables (TPC, fecal coliform, E. coli and coliphage) to the occurrence of C. difficile. 
Significant differences among odds ratios were determined using Kruskal-Wallis test (α = 
0.05). Analysis of Variances (ANOVA) was performed on a 0.05 confidential level to 
determine significance among data points. Software IBM SPSS Statistics (v. 19.0.0) was used 
for statistical analyses.  
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CHAPTER 4 
RESULTS 
4.1 Aerobic plate count 
The results for aerobic plate count are presented by area in Fig. 4.1. Between January, 2013 
and February, 2014, 19 oyster samples were obtained from area 9, 10, 11, 12 and 13. Highest 
count in area 9 was 6.46CFU/100g and the lowest was 4.70 CFU/100g. From area 10, two 
samples were obtained, the aerobic counts were 5.01 and 6.46logCFU/100g. Maximum 
counts for samples from area 11, 12 and 13 were 5.80, 6.03 and 6.65logCFU/100g and 
minimum were 4.50, 4.78 and 4.55logCFU/100g, respectfully. A relation between Aerobic 
plate counts and the occurrence of C. difficile in oysters was observed according to the 
statistical analysis (odds ratio = 3.211). 
4.2 Fecal coliform and Escherichia coli 
The fecal coliform and E. coli counts are showed in Table 4.1. Nineteen samples were 
collected and enumerated for fecal coliform and E. coli during January, 2013 – February, 
2014. Eleven of 19 (57.9 %) samples were tested positive for fecal coliform and the obtained 
MPN ranged from 20 to 104 per 100 gram of oyster sample. Six of 11 (54.5%) fecal 
coliform-positive samples were confirmed with E. coli and the most probable numbers (MPN) 
were ranged from 10 to 35 per 100 gram of oyster sample. Fecal coliforms were found at 
least once in each area while E. coli was not confirmed in oyster sample from area 10. 
Despite the sampling area, there were more fecal coliforms observed in colder months. Seven 
of 10 positive samples were obtained in January-April and November and the average fecal 
coliform MPN/100g was higher in comparison to that obtained from June to October (52 vs. 
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6.2). Generally, fecal coliform and E. coli showed a different behavior than did aerobic plate 
count. A binary logistic regression model was used to evaluate the influence of Fecal 
coliform in the occurrence of C. difficile while no statistical significance was found (Table 
4.3). The model was proved to be effective by a Chi-square test (p>0.05). 
 
    
   
 
 
 
 
Figure 4.1 Average aerobic plate counts for oyster samples collected from harvesting areas 
along the Louisiana Gulf Coast. (A) Area 9; (B) Area 10; (C) Area 11; (D) Area 12; (E): 
Area 13. 
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Table 4.1 C. difficile, fecal coliform, E. coli and coliphage in oysters and harvesting water a 
Date   
C. difficile  
Fecal 
coliform  
E. coli  
Male-specific(F+) 
Coliphage  
Somatic 
Coliphage  Oysters 
Harvesting 
water 
13-Jan + NAb 94 35 < 6.0 < 6.0 
13-Jan - NA 95 20 7.7 32 
13-Feb - NA 35 < 2 < 6.0 < 6.0 
13-Mar - NA 60 < 2 < 6.0 < 6.0 
13-Apr + NA 104 < 2 < 6.0 < 6.0 
13-Apr - NA 50 35 < 6.0 < 6.0 
13-Jun - NA 20 20 20.8 < 6.0 
13-Jun - NA 10 10 10.8 < 6.0 
13-Jul + NA < 2 < 2 < 6.0 < 6.0 
13-Jul + NA < 2 < 2 < 6.0 < 6.0 
13-Jul + NA < 2 < 2 < 6.0 < 6.0 
13-Aug - - < 2 < 2 < 6.0 < 6.0 
13-Aug + - < 2 < 2 < 6.0 < 6.0 
13-Sep + + 32 10 < 6.0 < 6.0 
13-Sep - - < 2 < 2 < 6.0 < 6.0 
13-Oct - - < 2 < 2 < 6.0 < 6.0 
13-Nov + + 30 20 < 6.0 11.4 
13-Nov + + < 2 10 < 6.0 < 6.0 
14-Feb - - < 2 < 2 < 6.0 < 6.0 
a the results are expressed in the following manners: C. difficile (+/-); Fecal coliform and E. coli (CFU/100g);  
Male-specific (F+) and Somatic Coliphage (PFU/100g) 
b Date: year-month 
c NA: not available  
 
Table 4.2. Presence of C. difficile in sewage 
Date a   
Influent 
Sewage 
  
Effluent 
Sewage 
13-Sep 
 
+ 
 
+ 
13-Oct 
 
+ 
 
+ 
13-Nov 
 
+ 
 
+ 
14-Jan 
 
+ 
 
+ 
14-Feb   +   + 
a Date: year-month 
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Table 4.3. Exp (B) (odds ratio)of microbial indicators  
Microbial 
indicator 
Exp (B) 
Fecal 
coliform 
1.025a 
E. coli 0.997b 
APC 3.211c 
a per unit increase in fecal coliform count will result in a 2.5% higher possibility of C. difficile occurrence; 
b per unit increase in E. coli count will result in a 0.3% lower possibility of positive C. difficile  
c per unit increase in Aerobic plate count will result in a 221.1% higher possibility of positive C. difficile 
4.3 Coliphage  
The Male-specific (F+) Coliphage and Somatic Coliphage test results are showed in   
table 4.1. For Male-specific (F+) Coliphage, 3 positive results were seen in 19 oysters; for 
Somatic Coliphage, only 2 positive responses were seen in 19 oysters. The Male-specific 
(F+) Coliphage counts were 7.7, 20.8 and 10.8 PFU per 100g oysters. The Somatic 
Coliphage counts were 32.0 and 11.4 PFU per 100g oysters. 
4.4 Presence of C. difficile in oysters and waters 
Figure 4.3-4.6 and Table 4.1, 4.2 show the real-time PCR results obtained from oysters, 
harvesting water and sewage. From January, 2013 to February, 2014, 19 oysters, 8 harvesting 
waters and 5 sewage samples were collected and tested for pathogenic Clostridium difficile 
strains by CDSA and real-time PCR. For oysters collected prior to August-2013, frozen 
homogenates being kept at -20℃ were used. The frozen temperature (-20℃) was proved to 
have little impact on the survival of C. difficile spores (Freeman and Wilcox 2003).  
Nine out of 19 oyster samples (47.3%) were tested positive for C. difficile by CDSA and 
100% (9/9) of the C. difficile collected from CDSA were positive for tcdB gene by real-time 
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PCR. Three of 8 (37.5%) collected harvesting water samples were tested positive by CDSA 
and all were confirmed of virulence by real-time PCR. All five sewage samples, influent or 
effluent, tested positive in both tests. Pathogenic C. difficile were found in harvesting waters 
(except one sample from area 12) when the oyster samples from same harvesting area were 
tested positive.  
Oyster samples collected between warm months (June - September) showed more 
positive (5 vs. 4) in than those collected in other months, but the difference was not 
significant. In real-time PCR, oyster and harvesting water samples mostly crossed the 
threshold at 38~40 cycles while the sewage samples tended to cross the threshold at 24~26 
cycles. This might indicate that the C. difficile strains found in sewage were more robust than 
those in environmental samples and presented higher copy numbers in each colony on CDSA 
plates. The similar behavior of influent and effluent sewage sample in real-time PCR also 
showed that waste water treatment might have limited impact on the robustness of C. difficile 
spores.  
Our observation was partly in accordance to the report of Romano et.al in the year of 
2012, in which 85% C. difficile isolates from nine waste water treatment plants were found to 
be toxigenic (Romano and others 2012). To validate the method, an internal positive control 
was used. C. difficile ATCC 43255, a toxin B-positive C. difficile strain was used and gave a 
stable threshold cycle of around 25 cycles in each test. 
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Figure 4.3. Real-time PCR results for sewage sample collected in September, 2013 (A5, A6), 
October, 2013 (A7, A8), November, 2013 (A9, A10) and Oyster samples collected in January, 
2013 (A11, A12).    
 
Figure 4.4 Real-time PCR results for Oyster samples from area 9 (A5, A6), 10 (A7, A8), 11 
(A1, A2), 13 (A3, A4: August, 2013; A9, A10: November, 2013). 
 
Figure 4.5 Real-time PCR results for oysters from area 10 (A1, A2) and 12 (A3, A4), 
harvesting water from area 10 (A5, A6) and 12 (A7, A8), influent sewage (A9, A10).  
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Figure 4.6 Real-time PCR results for oysters from area 9 (A5, A6), 10 (A1, A2), 12 (A3, A4) 
and harvesting water from area 9 (A7, A8). And sewage water sample received in February 
(A10, A11). 
  
 4.5 PCR-ribotyping of C. difficile 
 The PCR ribotyping was performed on extracted DNAs that gave positive results in CDSA 
and real-time PCR tests. Nine oyster samples, 3 harvesting samples and all sewage samples 
were involved in the test. The gel images are shown in Figure 4.3-4.6. All sewage samples 
(both influent and effluent) were characterized with two bright bands between 200-500bp, 
which was obviously different from the banding pattern obtained from oysters and harvesting 
water. Multiple pale bands were observed between 200bp-400bp for most oyster and water 
samples but with one exception: harvesting water sample from area 12, collected in 
November, 2012 showed a similar banding pattern to sewage samples.  
Oyster and water samples collected from same areas tended to present same banding 
pattern (Figure 4. 7, C, D vs. E, F; Figure 4.8 E, F vs. G, H) but different banding patterns 
were also found in harvesting waters and oyster in samples from area 12, November, 2012. 
Oyster samples coming from same harvesting area but different sampling time (e.g. Area 9, 
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July vs. September, in Figure 4.7, lane C and D vs. Figure 4.9, lane D and E) showed 
different banding patterns, indicating the existence of various C. difficile strains in one 
sampling location.  
 
Figure 4.3 PCR ribotyping results for oysters and waters. Lanes: A and B: sewage 
influent\effluent, area 9, 13-S3ep; C and D, oysters, area 9,13-Sep; E and F, harvesting water, 
area 9, 13-Sep; G: oysters, area 12, 13-Nov; MW: 1000bp molecular marker. 
 
 
 
Figure 4.4 PCR ribotyping results for oysters and waters. Lanes: A, oysters; area 12 13-Nov; 
B and C, harvesting water, area 12, 13-Nov; D and E, oysters, area 13, 13-Nov; F and G, 
harvesting water, area 13, 13-Nov; H: sewage influent, 13-Nov;  
 
A     B     C     D     E     F     G     MW 
A     B     C     D     E     F     G     H 
-200bp 
-600bp 
-600bp 
-200bp 
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Figure 4.5 PCR ribotyping results for oysters and waters. Lanes: A, oysters; area 12 13-Jan; B 
and C, oysters, area 10, 13-Apr; D and E, oysters, area 9, Jul/2013; F and G, sewage 
influent/effluent, 13-Oct; H: sewage influent, 13-Nov. 
 
 
 
Figure 4.6 PCR ribotyping results for oysters and waters. Lanes: A and B, sewage influent/effluent, 
14-Jan; C and D, sewage influent/effluent, 14-Feb; E and F, oysters, area 10, 13-Jul; G and H, oysters, 
area 11, 13-Jul; H: sewage effluent, 13-Nov 
 
 
 
 
 
 
 
A     B     C     D     E     F     G     H 
-600bp 
-200bp 
A     B     C     D     E      F     G     H 
-600bp 
-200bp 
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CHAPTER 5 
DISCUSSION 
The purpose of this study was to provide a general idea about the prevalence of epidemic     
C. difficile in Louisiana oysters, harvesting water and sewage, and investigate the potential of 
fecal coliforms and coliphage as indictors for C. difficile. 
As a common resident of intestinal tracts and a spore former, C. difficile can enter the 
environment through various routes and survive theoretically a longer lifespan than common 
fecal pathogens (Freeman and Wilcox 2003). In a survey performed in the waste water 
treatment plants in Southern Switzerland, pathogenic C. difficile was found in both raw 
sewage influents and treated effluents, which revealed the possible contamination of water 
bodies that receive waste water treatment plant effluents (Romano and others 2012). As the 
distribution of Clostridium spp. by WWTPs in water ecosystems has been determined, the 
possible spreading of C. difficile in water bodies through treated sewage discharge should be 
of particular concern.  
Besides river water, which is usually first to receive sewage discharge, the presence of C. 
difficile in seawater was also reported by AI Saif and coworkers (1996), who found C. 
difficile in 7 (44%) of 15 sea water samples collected from Europe coastal areas, in the year 
of 1996. Oysters, on the other hand, are brackish filter-feeders and have a strong ability to 
concentrate micro particles, including pathogens and spores, within their bodies. V. Pasquale 
and coworkers reported that 12 known different PCR ribotypes of C. difficile were found in 
49% of the 53 marine bivalve molluscs in Europe.  
Although many studies have proven the effective defense of C. difficile by healthy 
intestinal flora, the consumption of contaminated oysters still impose great health risk to 
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vulnerable population (e.g. elder people who receive antibiotic treatment frequently), as C. 
difficile become highly contagious within health care facilities.  
In this study, 9 (47.4%) of 19oyster samples collected from five commercial harvesting 
areas were positive for toxin-B positive C. difficile by a two-step culturing-PCR method. Our 
results are comparable to those (49% and 42.8%) obtained by two independent studies with 
shellfish (Pasquale and others 2012) in Europe. The high detection rate indicates the 
accumulation of pathogenic C. difficile in oysters and the potential of oysters as a 
transmission source of C. difficile among people who consume oysters raw.  
A slightly lower proportion of positive results were obtained from harvesting waters, in 
3 (37.5%) of 8 samples, in comparison to the detection rate of C. difficile in oysters (47.4%). 
The difference might partly resulted from the oysters’ ability to largely concentrate spore 
particles, which are originally distributed sparsely in water bodies. In addition, the presence 
of C. difficile in oysters and harvesting water was almost identical, with 7(87.5%) of 8 
harvesting water samples showed same real-time PCR results as oysters collected from same 
area. Moreover, Willis and coworkers (1957), has reported a seasonal fluctuation of 
Clostridium Perfringens: generally higher counts were obtained in the colder months than in 
the summer in treated water (Willis 1957). However, no such trend was observed in this study 
since the number of positive C. difficile detected in cold months (5) was very close to that in 
warm months (4), indicating temperature might not be a decisive factor of the presence of   
C. difficile in oysters. 
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Aerobic plate count was performed with each test and was used to evaluate microbial 
abundance, which can be largely affected by temperature, weather and human/animal 
activities. According to our results, all sampling areas were affected similarly throughout the 
study since no significant fluctuation in the aerobic counts were observed. The high aerobic 
plate counts were obtained mostly in warm months (From June to October), during which 5 
(50%) of 10 collected oyster samples were tested positive for C. difficile. Moreover, 
pathogenic C. difficile was always found in samples with high aerobic plate count (e.g. 
oysters from area 9, 10, 11 in July/2013) from each sampling area. The statistical analysis 
revealed a relation between the aerobic plate count and the occurrence of C. difficile in 
oysters (odds ratio = 3.221), while still APC can hardly regarded as a bio-marker of         
C. difficile due to the lack of specificity. 
The open or closure of shellfish harvest areas is decided by the counts of fecal coliforms 
present in their surface waters. According to FDA’s National shellfish sanitation program 
manual of operations, 1997 revision, unrestricted shellfish harvesting areas should bare a 
mean fecal coliform MPN of less than 14/100 ml, with 10% of the samples not to exceed 
MPN of 43/100 ml in a five-tube MPN test. It was also reported that the accumulation of 
fecal coliforms by oysters in the Gulf Coast averaged 4.4 (SD = 4.0) times greater than their 
exposure in the waters. The maximum acceptable fecal coliform count in oysters could be 
calculated by multiplying the maximum acceptable fecal coliform count in water (14 
MPN/100ml) by 8.4 (mean accumulation factor + SD). Therefore, fecal contamination might 
have happened if the tested fecal coliform count rose over 118 MPN/100g oysters. The 
highest MPN of fecal coliform was observed in oysters collected in April, 2013, that had 
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108MPN/100g. Therefore, no fecal contamination might have happened in the harvesting 
areas throughout the study. In addition, according to past data obtained in coastal region of 
Louisiana, the mean counts of fecal coliforms in water peaked in late winter 
(January/February) reaching 120 MPN (February 1990), 165 MPN (January 1992), and 86 
MPN (January 1997), and then decreased considerably during spring and summer (1.2 - 19 
MPN). Our results agreed with previous data had an average fecal coliform count of 28 
MPN/100g, with peak values recorded as 104MPN/100g in April and 95MPN/100g in 
January. In comparison to the counts in colder months, the fecal coliforms counts in summer 
(From June to October) were significantly lower and gave an average counts of 6.9 
MPN/100g, with peak values recorded as 32MPN/100g. Eight of 10 samples collected 
between June and October were giving less than 2MPN/100g fecal coliform. Most (7/10, 
70.0%) positive fecal coliform in oyster samples were further confirmed as E. coli. Two = 
higher fecal coliform counts found in January and April were found to yield positive C. 
difficile as well. This showed that the increased environmental fecal coliforms and E. coli 
concentration might relate to the presence of C. difficile. However, in summer, the fecal 
coliform counts naturally became pretty low and failed to give ideal overlap (1 of 5, 20.0%) 
for C. difficile. This may partly attributed to the ability of C. difficile to form resistant spores 
that are better adaptive to changing environmental conditions, and may thus live a longer 
lifespan in summer in comparison to fecal indicators. Overall, the overlap of positive fecal 
coliform/E. coli and C. difficile were 4 (44.4%) of 9 samples. No significant relation was 
observed between the fecal coliform count and the occurrence of C. difficile. For fecal 
coliforms, increase in per unit of count only increase 2.5% of the possibility to observe C. 
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difficile; For E. coli, per unit increase in count will decrease 0.3% of the possibility of 
positive C. difficile. Therefore, the fecal coliform actually affect very little on the occurrence 
of C. difficile. 
The aim of PCR-ribotpying in this study was to determine whether the presence of      
C. diffcile i0.3%n oysters harvesting areas is related to the discharge of treated sewage from 
upstream WWTP. According to our results, similar C. difficile ribotype were found in all five 
sewage samples collected from the studied WWTP. Therefore, if the outflow of treated 
sewage does contribute to the accumulation of C. difficile spores in harvesting areas, similar 
C. difficle ribotype should be found in oysters and harvesting waters from these areas. 
However, except for one harvesting water sample from area 12, all other oysters and water 
samples formed very obvious different banding patterns to those obtained from sewage 
samples.  
The results suggested that the presence of C. difficile in oyster harvesting areas does not 
necessarily related to the sewage effluent discharged by upstream WWTP. Similar conclusion 
were also given by Willis, who found two samples of river water taken upstream from the 
studied WWTP were also positive for C. difficile (Willis 1957). Theoretically, the source of  
C. difficile found in WWTP was limited to human sewage, while the C. difficle found in 
oysters and harvesting water might derive from multiple sources: soil runoff, storm, sewage, 
feces of human, birds or other animals. Therefore, it is not so surprising to observe that     
C. difficile found in WWTP were similar while those found in environmental samples vary. 
This explanation was partly supported by our results: an inconsistency of C. difficile ribotype 
was found in same sampling area at different times (Figure 4.9 Lane A vs. Fugire 4.8 Lane A), 
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which suggests that multiple sources might be responsible for the spread of C. difficile in 
harvesting waters and oysters.  
We found a randomized pattern of Male-specific (F+) Coliphage and Somatic Coliphage 
distributions in oyster samples collected. The overall PFU too low to fit in statistical models. 
The overlap of positive Male-specific (F+) Coliphage and positive C. difficile were low, with 
only 1 in 9 samples. As for Somatic Coliphage, the overlap was only 2 of 9. The lack of PFU 
higher than 6/100g samples has prevented us in further investigating possible relations 
between the emergence of C. difficile and the abundance of coliphage in oysters.  
Our observation were partly in accordance to a previous study reported that no 
Male-specific (F+) Coliphage was found in oyster samples they collected from Gulf Coast 
areas(Burkhardt and Calci 2000). The lack of coliphage in shellfish was also reported in a 
study about the microbiological quality of shellfish-growing waters(Chai and others 1994). 
Hereby we regarded coliphage as an inappropriate indicator of C. difficile in oysters, on one 
hand due to its low detection rate in oysters (only in 3 samples had higher PFU than the 
detection limit of this method, 6 PFU/100g, in total 19 oyster samples ) and on the other hand 
its low overlap rate to C. difficile. Actually, the lack of correlation between coliphage and 
Clostridium Perfringens, a close relative to C. difficile, has been reported in a previous 
study(Burkhardt and Calci 2000).  
 
 
 
 
 55 
 
CHAPTER 6 
CONCLUSION 
The epidemiology of C. difficile has been changing, due in part to the emergence of more 
virulent C. difficile strains (NAP1/BI/027) in North America and Europe and the increasing 
proportion of C. difficile-associated diarrhea in the community. Moreover, C. difficile appears 
to be a growing concern in food producing animals and has been isolated from food products. 
Therefore, CDAD is no longer simply a health care-associated phenomenon, but a much 
more complicated epidemic disease that causes public health problems and financial loss. 
Foods, recreational waters, risk factors other than antimicrobial exposure should draw more 
attention as we begin to understand the broader scope of this microorganism. In this study, a 
high percentage of occurrence of pathogenic C. difficile strains in oysters, harvesting water 
and sewage flows was observed. The potential of fecal bacteria and coliphage as 
bio-indicators of C. diffcile was evaluated, while neither of them showed an ability to mark 
the presence of C. difficile in changing weather conditions. The lack of reliable indicator thus 
raises a task on the development of more sensitive and rapid quantification method of      
C. difficile in complicated weather and geological environments. Although epidemic C. 
difficile strains were detected frequently in both raw and treated sewage, no significant 
linkage was found in this study, between the occurrence of C. difficile in oysters, harvesting 
waters and discharge of treated sewage from upstream. This suggested the existence of 
possible alternative sources of C. difficile, besides sewage outflows, attributing to the 
transmission of C. difficile into harvesting areas.  
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